RxSight Inc [RXST] stock is trading at $14.98, up 1.77%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RXST shares have gain 1.73% over the last week, with a monthly amount drifted -40.60%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
RxSight Inc [NASDAQ: RXST] stock has seen the most recent analyst activity on April 15, 2025, when Piper Sandler initiated its Neutral rating and assigned the stock a price target of $18. Previously, UBS downgraded its rating to Neutral on April 09, 2025, and kept the price target unchanged to $16. On April 04, 2025, downgrade downgraded it’s rating to Underweight and revised its price target to $17 on the stock. BofA Securities downgraded its rating to a Underperform and decreased its price target to $22 on April 03, 2025. Stifel downgraded its rating to a Hold and reduced its price target to $40 on December 20, 2024. Wells Fargo downgraded its rating to Equal Weight for this stock on December 11, 2024, and downed its price target to $42. In a note dated December 06, 2024, UBS initiated an Buy rating and provided a target price of $52 on this stock.
RxSight Inc [RXST] stock has fluctuated between $13.50 and $66.54 over the past year. Currently, Wall Street analysts expect the stock to reach $70.11 within the next 12 months. RxSight Inc [NASDAQ: RXST] shares were valued at $14.98 at the most recent close of the market. An investor can expect a potential return of 368.02% based on the average RXST price forecast.
Analyzing the RXST fundamentals
RxSight Inc [NASDAQ:RXST] reported sales of 139.93M for the trailing twelve months, which represents a growth of 40.71%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at -0.25%, Pretax Profit Margin comes in at -0.18%, and Net Profit Margin reading is -0.18%. To continue investigating profitability, this company’s Return on Assets is posted at -0.09, Equity is -0.11 and Total Capital is -0.13. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.69 points at the first support level, and at 14.40 for the second support level. However, for the 1st resistance point, the stock is sitting at 15.17, and for the 2nd resistance point, it is at 15.36.
Ratios To Look Out For
For context, RxSight Inc’s Current Ratio is 11.36. In addition, the Quick Ratio stands at 10.50 and the Cash Ratio stands at 0.65. Considering the valuation of this stock, the price to sales ratio is 4.35, the price to book ratio is 2.15.
Transactions by insiders
Recent insider trading involved Fountain Tamara, Director, that happened on Mar 12 ’25 when 7000.0 shares were sold. Director, TAMARA R FOUNTAIN completed a deal on Mar 12 ’25 to buy 7000.0 shares. Meanwhile, Director Maniar Shweta sold 3519.0 shares on Jan 22 ’25.
